Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1985 2
1986 1
1987 4
1988 2
1990 1
1991 3
1992 1
1993 3
1994 1
1995 1
1996 1
1998 1
1999 2
2000 2
2002 1
2003 1
2004 2
2005 1
2009 1
2011 1
2012 2
2013 1
2014 2
2016 1
2017 1
2019 1
2020 3
2021 6
2022 5
2023 4
2024 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean p bray[Author] (2,105 results)?
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson JS, Suskind DL, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen BL, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H; DINE-CD Study Group. Lewis JD, et al. Among authors: braly k. Gastroenterology. 2021 Sep;161(3):837-852.e9. doi: 10.1053/j.gastro.2021.05.047. Epub 2021 May 27. Gastroenterology. 2021. PMID: 34052278 Free PMC article. Clinical Trial.
The percentage of participants who achieved symptomatic remission at week 6 was not superior with the SCD (SCD, 46.5%; MD, 43.5%; P = .77). FC response was achieved in 8 of 23 participants (34.8%) with the SCD and in 4 of 13 participants (30.8%) with the MD (P = .83 …
The percentage of participants who achieved symptomatic remission at week 6 was not superior with the SCD (SCD, 46.5%; MD, 43.5%; P = …
Dostarlimab and niraparib in primary advanced ovarian cancer.
Hardy-Bessard AC, Pujade-Lauraine E, Moore RG, Montestruc F, Redondo A, Mirza MR, Cibula D, Ciuleanu TE, Gilbert L, Eitan R, Zagouri F, Pignata S, Glasspool R, Pfisterer J, Phaëton R, Anderson CK, Rodrigues M, Gaba L, Bakirtzi E, Fauci JM, Kalbacher E, Musa FB, Gorman S, Duska LR, Gladieff L, Braly P, Joly F, Thomes Pepin J, Ray-Coquard I, Moore KN. Hardy-Bessard AC, et al. Among authors: braly p. Ann Oncol. 2025 Dec;36(12):1503-1513. doi: 10.1016/j.annonc.2025.05.009. Epub 2025 Jun 2. Ann Oncol. 2025. PMID: 40461381 Free article. Clinical Trial.
There was a statistically significant difference in PFS in arm 3 versus arm 2 (median 20.6 versus 19.2 months; hazard ratio [HR] 0.85, 95% confidence interval [CI] 0.73-0.99, P = 0.0351). OS had reached 57% maturity and was not statistically significant (median 44.4 versus …
There was a statistically significant difference in PFS in arm 3 versus arm 2 (median 20.6 versus 19.2 months; hazard ratio [HR] 0.85, 95% c …
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel.
Chase DM, Herrstedt J, Miller EM, Gilbert L, Zub O, Mathews C, Angioli R, Teneriello M, Gropp-Meier M, Powell MA, Reyners AKL, Cloven NG, Eminowicz G, Gill SE, Maćkowiak-Matejczyk B, Pothuri B, Samouëlian V, Jain A, Boone J, Bouberhan S, Trinidad J, Braly P, Buttin B, Backes FJ, Sawyer B, Antony G, Garside J, Allonby O, McCourt CK, Mirza MR. Chase DM, et al. Among authors: braly p. Int J Gynecol Cancer. 2025 Aug;35(8):101935. doi: 10.1016/j.ijgc.2025.101935. Epub 2025 May 21. Int J Gynecol Cancer. 2025. PMID: 40616865 Free article. Clinical Trial.
In the overall population, the mean (95% CI) duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment was significantly longer in the dostarlimab arm (24.75 months [22.88 to 26.65 months]) than in the placebo arm (20.34 months [18.95 to 2 …
In the overall population, the mean (95% CI) duration of quality-adjusted time without symptoms of disease progression or toxicity of treatm …
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.
Grisham RN, Hopp E, Pennington K, Holloway R, Wenham RM, Blecharz P, Dockery L, Matsuo K, Salani R, Bidzinski M, Braly P, Celano P, Reid T, Seward S, Lewis J, Johnson M, DuBose R, Ahn S, Cheng S, Alvero C, Konstantinopoulos PA. Grisham RN, et al. Among authors: braly p. Clin Transl Med. 2026 Jan;16(1):e70568. doi: 10.1002/ctm2.70568. Clin Transl Med. 2026. PMID: 41518037 Free PMC article. Clinical Trial.
A single somatic missense mutation in FOXL2, c.402C > G (p.Cys134Trp), has previously been identified in the majority of GCT and is a pathognomonic marker for this tumour type. ...
A single somatic missense mutation in FOXL2, c.402C > G (p.Cys134Trp), has previously been identified in the majority of GCT and i …
Single-Position Prone Lateral Lumbar Interbody Fusion Increases Operative Efficiency and Maintains Safety in Revision Lumbar Spinal Fusion.
Buckland AJ, Proctor DJ, Thomas JA, Protopsaltis TS, Ashayeri K, Braly BA. Buckland AJ, et al. Among authors: braly ba. Spine (Phila Pa 1976). 2024 Feb 1;49(3):E19-E24. doi: 10.1097/BRS.0000000000004699. Epub 2023 Apr 27. Spine (Phila Pa 1976). 2024. PMID: 37134133
RESULTS: 101 patients undergoing revision LLIF surgery were included, of which 43 had P-LLIF and 58 had L-LLIF. Age, BMI and CCI were similar between groups. The number of posterior levels fused (2.21 P-LLIF vs. 2.66 L-LLIF, P =0.469) and number of LLIF level …
RESULTS: 101 patients undergoing revision LLIF surgery were included, of which 43 had P-LLIF and 58 had L-LLIF. Age, BMI and CCI were …
Lateral decubitus single position anterior posterior surgery improves operative efficiency, improves perioperative outcomes, and maintains radiological outcomes comparable with traditional anterior posterior fusion at minimum 2-year follow-up.
Buckland AJ, Braly BA, O'Malley NA, Ashayeri K, Protopsaltis TS, Kwon B, Cheng I, Thomas JA. Buckland AJ, et al. Among authors: braly ba. Spine J. 2023 May;23(5):685-694. doi: 10.1016/j.spinee.2023.01.001. Epub 2023 Jan 12. Spine J. 2023. PMID: 36641035
Significant differences were noted in age (62.4 vs 56.9; p .001) and smoking status (7% vs 16%; p=.023) between the LSPS and FLIP groups. LSPS demonstrated significantly lower Op time (97.7min vs 297.0 min; p<.001), fluoro dose (36.5mGy vs 78.8mGy; p …
Significant differences were noted in age (62.4 vs 56.9; p .001) and smoking status (7% vs 16%; p=.023) between the LSPS and F …
Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D, Braly K, Nuding M, Braly I, Hopp C, Twible H, Pope C, Hayden HS, Hoffman L, Zheng H, Wahbeh G, Suskind DL. Lee D, et al. Among authors: braly i, braly k. J Pediatr Gastroenterol Nutr. 2024 May;78(5):1135-1142. doi: 10.1002/jpn3.12196. Epub 2024 Apr 1. J Pediatr Gastroenterol Nutr. 2024. PMID: 38558411 Clinical Trial.

Microbiome analysis showed a significant increase in species richness over 4 weeks (p = 0.01). Compared to baseline, the relative abundance at week 2 and at week 4 was significantly increased for Bifidobacterium and Streptococcus and decreased for Blautia (p < 0.

…
Microbiome analysis showed a significant increase in species richness over 4 weeks (p = 0.01). Compared to baseline, the relative abu …
Single position lateral decubitus anterior lumbar interbody fusion (ALIF) and posterior fusion reduces complications and improves perioperative outcomes compared with traditional anterior-posterior lumbar fusion.
Ashayeri K, Leon C, Tigchelaar S, Fatemi P, Follett M, Cheng I, Thomas JA, Medley M, Braly B, Kwon B, Eisen L, Protopsaltis TS, Buckland AJ. Ashayeri K, et al. Among authors: braly b. Spine J. 2022 Mar;22(3):419-428. doi: 10.1016/j.spinee.2021.09.009. Epub 2021 Sep 30. Spine J. 2022. PMID: 34600110
The SPLS cohort demonstrated significantly reduced operative time (132.95 77.45 vs. 261.79 91.65 min; p <0.001), EBL (120.44 217.08 vs. 224.29 243.99 mL; p <.001), LOS (2.07 1.26 vs. 3.47 1.40 days; p <.001), and rate of perioperative ileus (0.00% vs …
The SPLS cohort demonstrated significantly reduced operative time (132.95 77.45 vs. 261.79 91.65 min; p <0.001), EBL (120.44 217.0 …
Comparing Two Diets to Decrease Symptoms from Crohn's Disease – The DINE-CD Study [Internet].
Lewis JD, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson J, Suskind D, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen B, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H; DINE-CD Study Group. Lewis JD, et al. Among authors: braly k. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Oct. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Oct. PMID: 39312597 Free Books & Documents. Review.

Within the MD and SCD groups, from week 0 to week 6, there was improvement in the mean [SD] sCDAI score in the MD group ( 59.33 [64.53]; P < .0001) and the SCD group ( 71.78 [75.94]; P < .0001). However, the magnitude of change did not differ between the treat

…
Within the MD and SCD groups, from week 0 to week 6, there was improvement in the mean [SD] sCDAI score in the MD group ( 59.33 [64.53]; …
60 results